Q4 2025 · 13F-HR
AJU IB Investment Co., Ltd.holdings as filed
Filed 2026-02-10 · accession 0001140361-26-004468
$22.8M
Reported value
7
Positions
2025-12-31
Period end
The Brief · AJU IB Investment Co., Ltd. · Q4 2025
AI · grounded in 13F
AJU IB Investment Co., Ltd. reduced its position in KYMR by 95.7%. The fund also trimmed its holdings in STRO by 90% and ACLXGBX by 78.666%. These moves contributed to a total of three reduced positions across a portfolio with $22.79M in assets under management.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $14.6M | 63.9% | 223,486 | Common | SOLE |
| 75120L100 | RLYB | RALLYBIO CORP | $4.1M | 18.2% | 754,678 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $1.5M | 6.71% | 19,648 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $1.5M | 6.56% | 816,375 | Common | SOLE |
| 98422T100 | XLO | XILIO THERAPEUTICS INC | $427,488 | 1.88% | 667,742 | Common | SOLE |
| 75382E109 | RAPT | RAPT THERAPEUTICS INC | $421,241 | 1.85% | 12,437 | Common | SOLE |
| 869367102 | STRO | SUTRO BIOPHARMA INC | $202,475 | 0.89% | 17,500 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.